Therefore, this study aimed to systematically analyze risk factors for DS in a large cohort of newly diagnosed APL patients, with particular focus on clarifying whether baseline serum albumin represents a novel and clinically meaningful predictor. This evidence concerns the gene ALB and Dravet syndrome.